1/29/2014 7:55:36 AM
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, President and Chief Executive Officer, will present at the 16th Annual BIO CEO & Investor Conference on Monday, February 10, 2014, at 11:30 a.m. EST in the Conrad Room. The conference will be held at the Waldorf=Astoria Hotel in New York, NY.
Help employers find you! Check out all the jobs and post your resume.
comments powered by